Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy

Abstract The clinical responses observed following treatment with immune checkpoint inhibitors (ICIs) support immunotherapy as a potential anticancer treatment. However, a large proportion of patients cannot benefit from it due to resistance or relapse, which is most likely attributable to the multi...

Full description

Bibliographic Details
Main Authors: Yuze Wu, Ming Yi, Mengke Niu, Qi Mei, Kongming Wu
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Molecular Cancer
Subjects:
Myeloid-derived suppressor cells
Cancer immunotherapy
Immune checkpoint inhibitors
The tumor microenvironment
Arginase I
Inducible nitric oxide synthase
Online Access:https://doi.org/10.1186/s12943-022-01657-y

Internet

https://doi.org/10.1186/s12943-022-01657-y

Similar Items